Page 91 - Ram Prasad Sahu/workspace/business Standard Web/undefined

Value unlocking key trigger for Gateway

The stock saw some action recently after it announced plans to list its cold chain subsidiary

M&M gains from tractor, UV volumes

Tractors & Bolero are likely to see a volume uptick in second half on account of higher farm income and pre-election spending

Value unlocking key trigger for Gateway

Improving prospects on back of demand revival also play in its favour

Rural portfolio could reverse M&M's volume downslide

Tractors and utility vehicle Bolero likely to see volume uptick in second half of the fiscal

TVS Motor: The scooter is just puttering along

While exports have stood out, domestic volumes hinge on the performance of launches

Ranbaxy: New product launches, margins to be hit

The company is capacity constrained as Ohm Laboratories plant in the US is its only US-FDA approved option left after the Mohali import alert

Analysis: Difficult year ahead for TVS despite August performance

While exports have stood out, domestic performance continues to be weak

Tata Motors: Boost from strong JLR volumes

Analysts expect JLR to maintain double digit volume growth on launches, refreshes

Healthy dose of foreign sales to boost Cipla's fortunes

Overseas foray with front-end presence and a strong product pipeline will help the firm achieve $5-bn revenue target

Healthy dose of overseas sales to boost Cipla's fortunes

Overseas foray with front end presence coupled with strong product pipeline will help Cipla achieve its $5 billion target

Seven stars for your equity portfolio

Their positioning and prospects in the respective sectors should help these companies generate steady cash flows. That they have low debt and are available at reasonable valuations is a bonus

Niche play, alliances key for Biocon

Biosimilar opportunity in regulated markets will play out in medium run; biopharma, branded products will drive growth in short run

Niche play, alliances hold promise for Biocon

While biosimilar opportunity in the regulated markets is likely to play out in the medium term, its existing biopharma and branded products portfolio will ensure growth in the short term

Bharti: No more dropped calls

Operating environment in India, the biggest overhang for the stock, is improving

Higher tractor sales key trigger for Escorts

The good performance of the tractor segment and lower raw material costs as a percentage of revenues helped Ebitda margins to jump 260 basis points to 7.9%

First-to-file launches are key triggers for Ranbaxy

The FDA clearance for its 2 units, an overhang currently, should also help narrow the valuation gap with peers

First-to-file launches are key triggers for Ranbaxy

FDA clearance for its two units, which is an overhang currently, should help narrow valuation gap with peers

5 foul-weather friends for your portfolio

Amid the doom and gloom of cheaper currency and weaker markets, certain stocks hold great promise

Maestro's touch helps Hero weather headwinds

Its bestselling segment is battling a demand slump but scooters have helped

Hero MotoCorp: Riding alone, riding strong

The expected rebound in demand from rural markets and new launches, including those based on its own technology over the next 12-18 months, are triggers for the stock's re-rating